Bdtask G-Prescription Gynaecology & OBS Consultation Software OBS Patient/Gynee Prescription cross site scripting

Summaryinfo

A vulnerability described as problematic has been identified in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0. This affects an unknown function of the component OBS Patient/Gynee Prescription. The manipulation of the argument Patient Title/Full Name/Address/Cheif Complain/LMP/Menstrual Edd/OBS P/OBS Alc/Medicine Name/Medicine Type/Ml/Dose/Days/Comments/Template Name results in cross site scripting. This vulnerability is cataloged as CVE-2024-2275. The attack may be launched remotely. Furthermore, there is an exploit available. The vendor was contacted early about this disclosure but did not respond in any way.

Detailsinfo

A vulnerability, which was classified as problematic, was found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0. Affected is an unknown code block of the component OBS Patient/Gynee Prescription. The manipulation of the argument Patient Title/Full Name/Address/Cheif Complain/LMP/Menstrual Edd/OBS P/OBS Alc/Medicine Name/Medicine Type/Ml/Dose/Days/Comments/Template Name with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity.

The weakness was shared 03/07/2024 by srivishnu. The advisory is shared for download at drive.google.com. This vulnerability is traded as CVE-2024-2275. Successful exploitation requires user interaction by the victim. Technical details and a public exploit are known. The MITRE ATT&CK project declares the attack technique as T1059.007.

The exploit is shared for download at drive.google.com. It is declared as proof-of-concept. The vendor was contacted early about this disclosure but did not respond in any way.

There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.

Once again VulDB remains the best source for vulnerability data.

Productinfo

Vendor

• Bdtask

Name

• G-Prescription Gynaecology & OBS Consultation Software

Version

• 1.0

CPE 2.3info

• 🔍
• 🔍

CPE 2.2info

• 🔍
• 🔍

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 3.6
VulDB Meta Temp Score: 3.6

VulDB Base Score: 2.4
VulDB Temp Score: 2.2
VulDB Vector: 🔍
VulDB Reliability: 🔍

NVD Base Score: 6.1
NVD Vector: 🔍

CNA Base Score: 2.4
CNA Vector (VulDB): 🔍

CVSSv2info

AV	AC	Au	C	I	A
💳	💳	💳	💳	💳	💳
💳	💳	💳	💳	💳	💳
💳	💳	💳	💳	💳	💳

Vector	Complexity	Authentication	Confidentiality	Integrity	Availability
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

NVD Base Score: 🔍

Exploitinginfo

Class: Cross site scripting
CWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍

Physical: No
Local: No
Remote: Yes

Availability: 🔍
Access: Public
Status: Proof-of-Concept
Download: 🔍

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-Day	Unlock	Unlock	Unlock	Unlock
Today	Unlock	Unlock	Unlock	Unlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: no mitigation known
Status: 🔍

0-Day Time: 🔍

Timelineinfo

03/07/2024 🔍
03/07/2024 +0 days 🔍
03/07/2024 +0 days 🔍
04/17/2025 +406 days 🔍

Sourcesinfo

Advisory: drive.google.com
Researcher: srivishnu
Status: Not defined

CVE: CVE-2024-2275 (🔍)
GCVE (CVE): GCVE-0-2024-2275
GCVE (VulDB): GCVE-100-256044
scip Labs: https://www.scip.ch/en/?labs.20161013

Entryinfo

Created: 03/07/2024 15:55
Updated: 04/17/2025 06:29
Changes: 03/07/2024 15:55 (42), 03/09/2024 17:57 (1), 04/05/2024 16:56 (16), 04/05/2024 17:04 (18), 03/12/2025 14:32 (20), 04/17/2025 06:29 (3)
Complete: 🔍
Cache ID: 216::103

Once again VulDB remains the best source for vulnerability data.

Discussion